Becton, Dickinson and Co. (BDX)

Price$151.16

Value ScoreB

Growth ScoreC

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-8.82%

Price vs S&P 500 (4W)1.17%

VGM Score56.99

Market Capitalization$41.65B

P/E Ratio (Annual)24.82x

Indicated Dividend Yield (Annual)2.81%

All Metrics

P/CF (Annual)12.14x

Book Value / Share (Quarterly)$87.58

P/TBV (Annual)3.34x

Indicated Dividend (Annual)$4.20

Revenue Growth (3Y)4.99%

Cash Flow / Share (Quarterly)$11.14

Payout Ratio (TTM)67.90%

Price vs S&P 500 (YTD)-9.08%

Gross Margin (TTM)46.99%

Net Profit Margin (TTM)5.33%

EPS (TTM)$3.94

10-Day Avg Trading Volume2.54M

EPS Excl Extra (TTM)$3.94

Revenue Growth (5Y)6.32%

EPS (Annual)$5.82

Dividend / Share (Annual)$4.16

ROI (Annual)3.76%

Gross Margin (Annual)45.89%

Net Profit Margin (5Y Avg)8.83%

Cash / Share (Quarterly)$2.96

P/E Basic Excl Extra (TTM)36.60x

Revenue Growth QoQ (YoY)-10.58%

EPS Growth (5Y)13.42%

P/E Normalized (Annual)24.82x

ROA (Last FY)3.03%

Revenue Growth TTM (YoY)2.39%

EBITD / Share (TTM)$16.00

ROE (5Y Avg)6.97%

Operating Margin (TTM)10.23%

Cash Flow / Share (Annual)$9.36

P/B Ratio1.73x

P/B Ratio (Quarterly)1.86x

Net Income / Employee (Annual)$23,300

EV / Revenue (TTM)2.72x

Net Interest Coverage (TTM)4.00x

ROA (TTM)2.11%

EPS Growth QoQ (YoY)28.08%

EV / EBITDA (TTM)12.73x

EPS Incl Extra (Annual)$5.82

Current Ratio (Annual)1.11x

Quick Ratio (Quarterly)0.38x

3-Month Avg Trading Volume2.99M

52-Week Price Return12.42%

EV / Free Cash Flow (Annual)21.77x

P/E Incl Extra (TTM)36.60x

Revenue / Employee (TTM)$296,700

Tangible BV / Share (Quarterly)$57.28

P/S Ratio (Annual)1.91x

Asset Turnover (Annual)0.39x

52-Week High$187.35

Operating Margin (5Y Avg)11.58%

EPS Excl Extra (Annual)$5.82

CapEx CAGR (5Y)-0.24%

Tangible BV CAGR (5Y)9.94%

26-Week Price Return-0.90%

Quick Ratio (Annual)0.46x

13-Week Price Return-11.05%

Total Debt / Equity (Annual)0.76x

Current Ratio (Quarterly)0.94x

Enterprise Value$58.12B

Revenue / Share Growth (5Y)5.84%

Asset Turnover (TTM)0.40x

Book Value / Share Growth (5Y)1.66%

Revenue / Employee (Annual)$303,300

Inventory Turnover (Annual)3.05x

Pretax Margin (Annual)8.61%

Cash / Share (Annual)$2.27

3-Month Return Std Dev25.58%

Gross Margin (5Y Avg)45.57%

Net Income / Employee (TTM)$15,800

EBITDA CAGR (5Y)10.74%

EBITDA Interim CAGR (5Y)-2.75%

ROE (Last FY)6.61%

Net Interest Coverage (Annual)3.81x

EPS Basic Excl Extra (Annual)$5.82

P/FCF (TTM)13.57x

Receivables Turnover (TTM)8.16x

EV / Free Cash Flow (TTM)18.94x

Total Debt / Equity (Quarterly)0.72x

EPS Incl Extra (TTM)$3.94

Receivables Turnover (Annual)7.25x

ROI (TTM)2.59%

Dividend Growth Rate (5Y)3.22%

P/S Ratio (TTM)1.95x

Pretax Margin (5Y Avg)9.08%

Revenue / Share (Annual)$75.70

Tangible BV / Share (Annual)$56.01

Forward P/E11.22x

Free OCF CAGR (5Y)-0.73%

Price vs S&P 500 (52W)-11.95%

P/E Ratio (TTM)36.60x

EPS Growth TTM (YoY)-24.84%

Year-to-Date Return-0.92%

5-Day Price Return4.01%

EPS Normalized (Annual)$5.82

ROA (5Y Avg)3.21%

Net Profit Margin (Annual)7.68%

Month-to-Date Return2.75%

Cash Flow / Share (TTM)$13.03

EBITD / Share (Annual)$17.42

EPS Growth (3Y)-2.10%

Operating Margin (Annual)11.74%

LT Debt / Equity (Annual)0.69x

P/CF (TTM)10.88x

ROI (5Y Avg)4.08%

P/E Excl Extra (TTM)36.60x

LT Debt / Equity (Quarterly)0.61x

EPS Basic Excl Extra (TTM)$3.94

P/TBV (Quarterly)2.84x

Payout Ratio (Annual)71.28%

P/B Ratio (Annual)2.10x

Dividend / Share (TTM)$4.22

Inventory Turnover (TTM)3.20x

Pretax Margin (TTM)7.70%

Book Value / Share (Annual)$88.96

Price vs S&P 500 (13W)-19.31%

Net Margin Growth (5Y)7.14%

Dividend Yield (TTM)2.85%

Beta0.20x

P/FCF (Annual)15.60x

Revenue / Share (TTM)$76.13

ROE (TTM)4.54%

52-Week Low$127.59

vGradeB

gGradeC

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q2 262.90est. 2.80

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

3.61

3.70

3.71

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
BDXBecton, Dickinson and Co.	B	C	C	$151.16
SYKStryker Corporation	C	C	C	$305.66
MMM3M Company	C	F	C	$153.76
BSXBoston Scientific Corp.	C	B	D	$48.55
MDLNMedline Inc. Class A common stock	C	D	D	$33.61
RMDResMed Inc.	C	B	C	$196.04
DXCMDexCom, Inc.	C	B	C	$72.86
WSTWest Pharmaceutical Services, Inc.	D	C	B	$314.50
SOLVSolventum Corporation	C	D	B	$81.01
PENPenumbra, Inc.	F	C	B	$320.53
GMEDGLOBUS MEDICAL INC	B	A	C	$80.00

About

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, including needles, syringes, and sharps-disposal units, alongside prefilled devices, diagnostic instruments, reagents, and flow cytometry and cell-imaging systems. Following its 2025 spinoff, the company operates across four segments: Medical Essentials (34% of revenue), Interventional (28%), Connected Care (25%), and Biopharma (13%). International markets represent 43% of total sales.